Heterotopic ossification and clinical outcome in nonconstrained cervical arthroplasty 2 years after surgery: the Norwegian Cervical Arthroplasty Trial (NORCAT) by Jarle Sundseth et al.
ORIGINAL ARTICLE
Heterotopic ossification and clinical outcome in nonconstrained
cervical arthroplasty 2 years after surgery: the Norwegian
Cervical Arthroplasty Trial (NORCAT)
Jarle Sundseth1,2 • Eva Astrid Jacobsen3 • Frode Kolstad1 • Ruth O. Sletteberg3 •
Oystein P. Nygaard7,8,9 • Lars Gunnar Johnsen4,5 • Are Hugo Pripp6 •
Hege Andresen7 • Oddrun Anita Fredriksli8,9 • Erling Myrseth10 • John A. Zwart3,11
Received: 20 August 2015 / Revised: 23 March 2016 / Accepted: 25 March 2016 / Published online: 9 April 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Purpose Heterotopic ossification is a phenomenon in
cervical arthroplasty. Previous reports have mainly focused
on various semiconstrained devices and only a few publi-
cations have focused on ossification around devices that are
nonconstrained. The purpose of this study was to assess the
occurrence of heterotopic ossification around a noncon-
strained cervical device and how it affects clinical outcome
2 years after surgery.
Methods Thirty-seven patients were included from a
larger cohort of a randomized controlled trial (NORCAT)
which compared single-level cervical arthroplasty with
fusion. The occurrence of heterotopic ossification was
assessed with a CT scan and two neuroradiologists deter-
mined its degree. For grading, we used the Mehren/Su-
chomel classification system (grade 0–4). The patients
were divided by level of ossification, low grade (0–2) or
high grade (3–4), and clinical outcomes were compared.
Self-rated disability for neck and arm pain (Neck Disability
Index), health-related quality of life (the Short Form-36
and EuroQol-5D), and pain (the Numeric Rating Scale 11)
were used as clinical outcome measures.
Results Heterotopic ossification was encountered in all
patients 2 years after surgery. Complete fusion (grade 4)
was found in 16 % of participants, and high-grade ossifi-
cation (grade 3–4) occurred in 62 %. The remaining
patients were classified as having low-grade ossification
(grade 2). There were no differences in the clinical out-
comes of patients with low- and high-grade ossification.
Conclusion High-grade heterotopic ossification and
spontaneous fusion 2 years after surgery were seen in a
significant number of patients. However, the degree of
ossification did not influence the clinical outcome.
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Introduction
The gold standard for surgical treatment of cervical
radiculopathy has been cervical discectomy and fusion
(ACDF). However, studies on cervical fusion have reported
an increased adjacent-level intradiscal pressure and range
of motion [1–4]. The procedure has thus been perceived to
accelerate adjacent segment degeneration (ASD) [5, 6].
Accordingly, the introduction of anterior cervical discec-
tomy and arthroplasty (ACDA), which aims to preserve
motion at the operated level, has gained growing interest
among spinal surgeons. However, this interest is accom-
panied by concern with respect to heterotopic ossification
(HO), a well-known phenomenon in arthroplasty of the hip
and knee [7, 8]. It is also known to occur after arthroplasty
in the lumbar spine, and was described and classified in this
context by McAfee et al. [9]. After the introduction of
cervical arthroplasty, Mehren et al. [10] published their
classification system based on McAfee et al. [9]. The
degree of HO is described as low (grade 0–2) or high
(grade 3–4) [10], and in the last decade several reports have
been published in which the occurrence rate of HO varies
according to the disc prosthesis used [11–13]. Cervical
arthroplasty devices are usually manufactured to be semi-
constrained or nonconstrained. Semiconstrained devices
allow for motion similar to normal physiological move-
ment. Nonconstrained devices have no mechanical stop and
extremes of motion are prevented by the perispinal soft
tissue and inherent compression across the disc space [14].
Previously, reports regarding fusion (Mehren grade 4) have
focused mainly on semiconstrained devices [15]. Few
studies have assessed the occurrence of heterotopic ossifi-
cation and complete fusion in cervical nonconstrained
arthroplasty [16–18]. Heary et al. [16] presented a case
report where complete fusion was found 5 years after
surgery, and Skeppholm et al. [17] demonstrated complete
fusion in 5 % of their patients at an average of 40 months
follow-up. The present study was realized under the
framework of the Norwegian Cervical Arthroplasty Trial
(NORCAT) to assess to what degree preservation of
motion was maintained 2 years after surgery, and to
compare our results with previous reports. In addition, we
wanted to investigate if high-grade HO had an impact on
clinical outcome compared with low-grade HO.
Material and method
Study population
NORCAT is a prospective, randomized controlled, single-
blinded, multicenter trial on one-level ACDA versus
ACDF. One hundred and thirty-six patients were included
at five university hospitals in Norway during the time
period from November 2008 to January 2013. Seventy nine
out of 136 patients were included at the Department of
Neurosurgery, Oslo University Hospital Rikshospitalet,
Oslo, Norway. Of these, 39 were randomized to arthro-
plasty. Two patients had their arthroplasty device removed
before 2 years follow-up due to loosening and anterior
migration of the prosthesis. The present study is based on
the remaining 37 patients 2 years after surgery.
Inclusion criteria were age 25–60 years, clinical C6 or
C7 root radiculopathy with corresponding radiological
findings with or without neurological deficits, Neck Dis-
ability Index (NDI) C 30 %, no response to non-operative
treatment and no sign of improvement during the last
6 weeks prior to surgery.
Exclusion criteria were significant spondylosis involving
more than one level, adjacent-level ankylosis, intramedul-
lary changes on magnetic resonance imaging (MRI), clin-
ical suspicion of myelopathy, chronic generalized pain
syndrome, mental illness, infection, active cancer disease,
rheumatoid arthritis involving the cervical spine, previous
trauma involving the cervical spine, pregnancy, allergy to
the contents of the cage/artificial disc, previous neck sur-
gery, abuse of medication/narcotics, and that the patient did
not understand oral or written Norwegian.
Methods
Computed tomography (CT) of index level was performed
2 years after surgery on all 37 patients. The CT scans were
carried out with a multidetector scanner using bone algo-
rithm, dFOV 15–18 cm, between 80 and 100 mA and
120 kV, and 1 mm increment with coronal and sagittal
reconstructions. The images were evaluated twice by two
experienced neuroradiologists and assessed by consensus.
The radiologists were blinded with respect to clinical out-
comes. To assess the degree of HO, the Mehren classifi-
cation system was used (Fig. 1) and classified as either low
grade (grade 0–2) or high grade (grade 3–4).
The arthroplasty device
The arthroplasty device used in the present study was the
DISCOVER Cervical Arthroplasty Disc Replacement
System (DePuy Spine Inc., Raynham, Ma.). It is a non-
constrained device which comprises a titanium alloy
superior endplate with an ultrahigh molecular weight
polyethylene core that is mechanically fixed to the inferior
titanium alloy endplate (Fig. 2). The hard polymer core on
the inferior endplate articulates with the superior metal
endplate to form a ball-and-socket type of joint. Flexion–
extension and axial rotation are limited by musculoliga-
mentous restraints and the articulating surfaces. Lateral
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Fig. 1 The grade of heterotopic ossification (HO) was assessed using the Mehren classification system. Illustration by K. C. Toverud
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motion is limited to 21. The fixed inlay in combination
with a ball-and-socket superior articulation with limited
lateral motion has resulted in the device being described as
minimally constrained [19].
The surgical procedure
A standard discectomy via the anterolateral approach was
performed. The posterior longitudinal ligament was opened
to visualize the dura mater and the nerve roots were
decompressed. The endplates were trimmed with a dia-
mond burr. A fluoroscope was used to ensure that the
prosthesis was placed in the midline and sufficiently close
to the posterior edge of the vertebra. The appropriate size
of the prosthesis was determined with the use of templates.
Clinical outcome and baseline variables
Primary outcome measure
The primary outcome was the NDI [20], which is a self-
rated disability score of neck and arm pain. It is composed
of ten items: pain, personal care, lifting, reading, headache,
concentration, work/daily activities, driving, sleep, and
recreation. Each item is scored from 0 to 5. The score was
calculated in percentage where higher scores represent
worse function.
Secondary outcome measures
1. The Short Form-36 (SF-36) [21] is a generic health-
related quality of life questionnaire that measures
along eight dimensions: physical function, role limi-
tations due to physical problems, bodily pain, general
health, vitality, social function, role limitations due to
emotional problems, and mental health. There are two
summary measures: Physical Component Summary
(PCS) and Mental Component Summary (MCS).of
four to six items and score ranges from 0 to 100, where
a higher score is related to better health. We used the
Norwegian (chronic) version v 2.0 [22], and for scor-
ing the questionnaire, we used QualityMetric Health
Outcomes Scoring Software 2.0 (QualityMetric
Incorporated, Lincoln, USA).
2. The EuroQol-5 Dimension-3 level (EQ-5D-3L) [23]
questionnaire is applicable to a wide range of health
conditions and treatments, and provides a simple
descriptive profile and a single index value for health
status. The calculated index ranges from -0.59 to 1,
where a higher score represents better health. For
conversion to utilities, we used the time trade-off
method (TTO) and the UK tarif [24].
3. The Numeric Rating Scale 11 (NRS 11) [25] is a one-
dimensional pain scale from 0 to 10 where the two
extreme categories are labeled ‘‘no pain at all’’ and
‘‘worst imaginable pain’’. It was used for the descrip-
tion of arm and neck pain.
Statistics
Continuous data are described as mean and standard
deviation (SD) or median and interquartile range (IQR) as
appropriate, and were statistically tested between the
groups with independent T test or Mann–Whitney U tests
depending on assumptions on statistical distribution. Cat-
egorical data are described as number of patients and
percentage, and were tested with Pearson Chi-square tests
or Fischer exact tests as appropriate. To assess differences
in baseline characteristics between patients with low- and
high-grade HO, the demographics and baseline outcome
measures were analyzed. The level of significance was
defined as a p value\ 0.05. SPSS version 18.0 (IBM
Corporation, Armonk, New York) was used for all analysis.
Ethical considerations
The Regional Committee for Medical and Health Research
Ethics and the data protection official for research
approved the study. The study is registered at clinicaltri-
als.gov [26]. All patients included in the trial gave their
written informed consent to participate.
Results
The mean age at inclusion was 44 years (range
33–59 years). Twenty patients (54.1 %) were female. The
disc level C5/C6 was operated in 59.5 % and C6/C7 in
40.5 %. There were no statistically significant differences in
baseline characteristics between patients with low- and
high-grade HO (Table 1). HO was encountered in all
Fig. 2 Illustration of the DISCOVER disc prosthesis (DePuy Spine
Inc., Raynham, Ma.) Illustration by K. C. Toverud
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patients 2 years after surgery. Twenty-three patients
(62.2 %) had developed high-grade HO and complete
fusion was found in six (16.3 %). The remaining 14 patients
(37.8 %) were classified as grade 2 (Table 2; Fig. 3).
At 2 years follow-up, NDI scores (±SD) in patients with
low- and high-grade HO were 27.0 (±19.6) and 26.8
(±20.3), respectively (Fig. 4). The difference was not
statistically significant, p = 0.98; nor were there any sig-
nificant differences in any of the secondary clinical out-
come measures (Table 3).
There were no major perioperative complications.
However, out of 39 patients who were randomized to
arthroplasty at the Oslo University Hospital, Rikshospi-
talet, 2 patients (5.1 %) had undergone index level reop-
eration before 2 years follow-up, leaving 37 patients in the
present study. The reason for additional surgical treatment
was due to loosening and anterior displacement of the
arthroplasty device. Reoperations were performed with
removal of the prosthesis, followed by fusion with cage and
anterior plating.
Discussion
Cervical arthroplasty aims to preserve motion, but hetero-
topic ossification is an undesirable phenomenon in arthro-
plasty surgery which may cause reduced or absent mobility
at the operated level. The objective of this study was to
investigate the occurrence of heterotopic ossification
2 years after arthroplasty surgery, and to assess if the
degree of ossification had an impact on the clinical out-
come. The study was realized under the framework of the
Norwegian Cervical Arthroplasty Trial.
Trial limitations are the number of patients included,
which preclude firm conclusions about the study results.
Further, the images were evaluated by two neuroradiolo-
gists by consensus and not as interobserver variation with
kappa statistics.
HO was found in all patients 2 years after surgery. High-
grade HO was found in 62.2 % of the patients and a
complete fusion in 16.3 %. There were, however, no sig-
nificant differences in either the primary or secondary
outcome measures between patients with low- and high-
grade HO.
Table 1 Baseline characteristics of the patients with low- and high-








Age, years (±SD) 44.9 (7.4) 43.7 (6.7) 0.63
Female sex, no. (%) 9 (64.3) 11 (47.8) 0.40
Heights, cm (±SD) 170.4 (10.6) 174.3 (10.1) 0.29
Weight, kg (±SD) 72.1 (11.3) 81.7 (18.1) 0.09
Body-mass indexa (±SD) 25.6 (2.7) 26.5 (4.1) 0.52
Level operated C5/C6 (%) 10 (71.4) 12 (52.2) 0.14
NDI (±SD) 49.0 (15.0) 46.4 (12.5) 0.57
EQ-5D (±SD) 0.30 (0.29) 0.34 (0.35) 0.70
SF-36 PCS (±SD) 36.5 (5.7) 34.2 (7.8) 0.36
SF-36 MCS (±SD) 42.1 (11.5) 48.5 (11.1) 0.11
NRS neck pain, median (IQR) 6.5 (5–10) 6.5 (3–10) 0.34
NRS arm pain, median (IQR) 7 (3–10) 5 (0–10) 0.33
a The body mass index is weight in kilograms divided by the square
of the height in meters
Table 2 Distribution of patients according to the HO grade
HO
grade
0 1 2 3 4





Fig. 3 Distribution of heterotopic ossification (HO) 2 years after
surgery. Classification from 0 (no HO) to 4 (fusion) according to






















Fig. 4 Primary clinical outcome measure, the Neck Disability Index
between patients with low- and high-grade HO 2 years after surgery
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HO around cervical disc prostheses has been reported
with both semiconstrained and nonconstrained devices
[11–13, 15, 18]. However, the occurrence of complete
fusion (grade 4) with nonconstrained devices is rare. Tu
et al. [18] have previously reported this phenomenon with
the Bryan cervical disc (Medtronic Spine and Biologics).
Recently, it was also assessed in one clinical trial and in
one case report using the same arthroplasty device as in the
present study [16, 17].
A possible mechanism for HO development is related to
increased height and range of motion (ROM) of the oper-
ated level [27]. Devices that are nonconstrained, as used in
the present trial, cannot stop motion mechanically and are
reliant on perispinal soft tissue and compression across the
disc space to hinder extreme motion. Compared with other
studies, the occurrence of HO in the present trial was
higher than previously reported [10–13, 18, 28]. Zhou et al.
[11] included nine studies in their meta-analysis of HO in
both semiconstrained and nonconstrained devices. In six of
the studies, nonconstrained implants were used. Follow-up
ranged from 24 to 96 months and the occurrence of HO
ranged from 37.5 to 62 %. An early study of HO with the
Bryan Cervical Disc [12] found that 17.8 % of the patients
had developed HO 12 months after surgery. Yi et al. [13]
assessed HO after 20 months in both nonconstrained and
semiconstrained devices. With the nonconstrained devices,
Bryan and Mobi-C (LDR Medical, Troyes, France), HO
was found in 21.0 and 52.5 %, respectively. With the
semiconstrained device, ProDisc-C (Synthes, Inc., West
Chester, PA), HO was found in 71.4 %. Skeppholm et al.
[17] used the same arthroplasty device as in the present
study and found that HO caused complete fusion and very
limited motion in 5 and 8 %, respectively, after 40 months.
On the other hand, Qizhi et al. [29], who used the Discover
device in two-level disc surgery, found no HO after
32,4 months. Tu et al. [18] reported 50 % HO with the
Bryan device at a mean 19 months follow-up, and Sucho-
mel et al. [28] found high-grade HO in 63 % after 4 years
with the ProDisc-C. Thus, different degrees of constraints
seem to influence the development of HO, but HO also
differs among devices with the same degree of constraint
and in different reports concerning the same device. In the
present study, HO occurred in all implanted devices and
the degree of high-grade HO was approximately the same
as reported by Suchomel et al. [28], but in a much shorter
observation period. Possible explanations can be related to
implant design, suboptimal implantation of the prosthesis,
incorrect size of the device, or the individual surgical
technique, even though all surgeons had good experience
with the particular arthroplasty device.
A recent meta-analysis comparing multi-level and sin-
gle-level ACDA found that the occurrence of HO did not
depend on the number of levels operated on [30]. The
presence of ASD, on the other hand, has recently been
found to significantly correlate with the development of
HO [31].
Park et al. found that surgical technique influenced the
development of HO [32]. In their study, two surgeons
performed all operations; however, they had different
techniques for trimming endplates. One surgeon used a
fluted ball-type burr, while the other used a diamond-type
burr. The study found that the use of fluted ball-type burr
resulted in significantly more HO. In the present study,
only diamond burrs were used to trim the endplates. Nev-
ertheless, HO was seen in all patients 2 years after surgery.
Several other possible causal factors regarding HO have
been discussed, such as not treating patients with nons-
teroidal anti-inflammatory drugs (NSAIDs) after surgery.
The use of NSAIDs to prevent HO after total hip
replacement has been reported previously [33]. The study
protocols of clinical trials for cervical arthroplasty under-
taken by the US Food and Drug Administration included
the perioperative use of NSAIDs as an attempt to prevent
the occurrence of HO. One study has reported a trend
toward decreased HO formation in patients who used
NSAIDs after cervical disc arthroplasty compared with
those who did not, but the difference was not statistically
significant [34]. NSAIDs were not used routinely in the
present trial and further studies should assess the role of
NSAIDs in the development of HO after cervical disc
arthroplasty.
Other predisposing factors that have been discussed are
age and gender. Male gender has previously been reported
to correlate with HO formation [35] and could be a
Table 3 Clinical outcome for
low- and high-grade HO 2 years
after surgery





mean difference (95 % CI)
p
NDI (±SD) 27.0 (19.6) 26.8 (20.3) 0.2 (-14.7 to 15.2) 0.98
EQ-5D (±SD) 0.76 (0.28) 0.68 (0.35) 0.08 (-0.16 to 0.33) 0.49
SF-36 PCS (±SD) 48.4 (9.5) 49.6 (11.0) -1.2 (-8.7 to 6.4) 0.76
SF-36 MCS (±SD) 53.8 (14.2) 48.9 (14.3) 4.9 (-5.4 to 15.1) 0.34
NRS neck pain, median (IQR) 3 (0.25–6) 4.5 (0.25–7.75) 0.74
NRS arm pain, median (IQR) 2.5 (0–6.75) 1.5 (0.25–4) 0.45
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contributing factor regarding the observed difference in
HO occurrence compared with other reports. However, the
present male/female ratio was not much different from the
other studies. There was no relationship between high- and
low-grade HO and age or gender in the present study.
Motion between two vertebrae occurs around a point
described as instantaneous axis of rotation (IAR). The IAR
is commonly located in the posterior half of the upper
portion of the inferior vertebral body, the central region of
the intervertebral disc, or the middle region of the subja-
cent vertebrae. However, there is not one axis of rotation in
the cervical spine. The IAR identifies the rotation of one
vertebra relative to another at a given point in time and will
change when the motion of the vertebral body consists of
both a translational and a rotational component. Artificial
cervical discs should have an axis of rotation that mimics
the kinematics of the normal spine to restore the physio-
logic range of motion and disc height and to transmit axial
loading forces from the superior to the inferior vertebral
body [36]. Some arthroplasty devices, like the
DISCOVER and the ProDisc-C, have a ball-and-socket
single-articulating design with a fixed center of rotation
(COR). With such devices, a posterior positioning of the
implant in the disc space is important. Others, like the
Bryan prosthesis, have double articulation surfaces and
independent translation, which allows for a mobile COR.
With a mobile COR, various positions of the device may
theoretically maintain physiologic kinematics. Whether an
altered COR due to implantation of an arthroplasty device
has clinical consequences in the long term is not yet
known. However, an imprecise position of the implant may
cause a negatively altered COR and perhaps influence HO
formation. Assuming that replication of a physiologic COR
is an important design feature of a cervical prosthesis,
Koller et al. found that ideal surgical preparation and ideal
positioning of the implant are most important to preserve
the segmental COR and balance [19].
Although the difference in HO formation was consid-
erable, the grade of HO did not influence the clinical out-
come in the present trial. However, our results do not
correspond with the findings of a recent meta-analysis
where patients with high-grade HO felt significantly less
pain than patients with low-grade HO [10]. The same study
also concluded that the presence of HO did not influence
the clinical outcome.
Fusion naturally prevents motion, and very limited
motion has recently been shown with HO [17]. Based on
the results from the present trial, it seems that the benefit of
cervical disc arthroplasty, namely preservation of physio-
logical motion, is of limited relevance with respect to the
clinical outcome. This is consistent with previous results
regarding arthroplasty in the lumbar spine [37].
Conclusion
High-grade HO and spontaneous fusion 2 years after sur-
gery were seen in a significant number of patients, but the
degree of ossification did not influence the clinical outcome.
However, conclusion about the effect of HO on the devel-
opment of adjacent-level degeneration and clinical outcome
in the long term, cannot be drawn. Trials with even longer
follow-up are needed for more definite answers concerning
HO and its impact on mobility as well as clinical outcome.
The main goal of cervical arthroplasty is preservation of
motion, which for a significant number of patients in the
present study was not achieved with the device under the
applied surgical techniques used in the NORCAT.
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